bioRxivGeneticsPreprint
A Forward Genetic Screen in Caenorhabditis elegans for Genes that Modulate α-synuclein-Induced Neurodegeneration through the Mitochondrial UPR
Karolina WillicottiD, Joy D. IroegbuiD, Madeline R. GreeneiD, Aidan C. MeyersiD, Rachel Martin, Rose Davidson-Tullis, Laura E. BerkowitziD, Guy A. CaldwelliD, Kim A. CaldwelliD
Abstract
Overexpression of -synuclein (-syn), an inherently disordered protein, triggers chronic activation of the mitochondrial unfolded protein response (UPRmt) pathway in Caenorhabditis elegans with enhanced dopaminergic (DAergic) neurodegeneration. Introduction of a loss-of-function(lf) mutation in atfs-1, the main transcriptional regulator of the UPRmt, into -syn nematodes results in significant neuroprotection from -syn-induced DA neuron loss, indicating that compensatory mechanisms provide neuroprotection. We performed a F3 forward genetic screen in C. elegans atfs-1(lf) mutants to identify molecular components associated with the modulation of neurodegeneration via UPRmt signaling in -syn-expressing DA neurons. Homozygous mutant animals were examined for enhanced neurodegeneration; multiple independent alleles were uncovered. Among these, we identified new nonsense alleles encoding the histone lysine demethylases (H3K27me3), jmjd-1.2 and jmjd-3.1. Another line carried a nonsense allele of twk-14. This gene encodes a conserved protein termed KCNK12 in mammals that facilitates passive background K+ leak currents to set and stabilize resting membrane potential. To further examine the association of these gene products in DA neurodegeneration, mutants and/or RNA interference were employed. DA neurodegeneration was observed in the -syn + atfs-1(lf) background when jmjd-1.2, jmjd-3.1, or twk-14 were individually depleted. These results provide evidence that jmjd-1.2 and jmjd-3.1, which encode previously characterized H3K27me3 demethylases, and the uncharacterized twk-14 gene product, orthologous to human KCNK12, naturally confer protection from -syn neurotoxicity.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An atfs-1 loss-of-function screen identifies novel regulators of a-synuclein toxicity in C. elegans dopaminergic neurons
Karolina Willicott, Joy D. Iroegbu, … Kim A. Caldwell·G3 Genes Genomes GeneticsPeer-reviewed·Sep 26, 2026
- Neuronal overexpression of mouse potassium channel subunit Kcnn1 in A53T α-synuclein mice more than doubles median survival time, associated with suppression of phospho-S129 α-synuclein formation
Maria Nagy, Wayne A. Fenton, Arthur L. Horwich·bioRxiv·Mar 18, 2026
- Protection from α-synuclein-induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20 in the rat midbrain
Briana R. De Miranda, Emily M. Rocha, … J. Timothy Greenamyre·npj Parkinson s DiseasePeer-reviewed·Dec 8, 2020
- Activation of the CaMKII-Sarm1-ASK1 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria
Chen Ding, Youjun Wu, … Marc Hammarlund·eLifePeer-reviewed·Jan 26, 2022
- Dopamine Abundance Uncouples Neurodegeneration and Lifespan in a C. elegans Model of Parkinson's Disease
Corey W. Willicott, Tyler J. Altman, … Kim A. Caldwell·bioRxiv·Jul 9, 2026
- Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
Jean-Louis A. Parmasad, Konrad M. Ricke, … Maxime W.C. Rousseaux·Cell Death and DiseasePeer-reviewed·Apr 4, 2024